Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders

Overview of attention for article published in Frontiers in immunology, October 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ARYL SULFONAMIDES AS BLT1 ANTAGONISTS

Application EP-3383868-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.